(Q40063867)

English

Constitutive activation of c-Met is correlated with c-Met overexpression and dependent on cell-matrix adhesion in lung adenocarcinoma cell lines

scientific article published on 22 October 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Constitutive activation of c-Met is correlated with c-Met overexpression and dependent on cell-matrix adhesion in lung adenocarcinoma cell lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hiroyuki Aburatani

7

object named as

Hiroyuki Aburatani

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

author name string

Yu Nakamura

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Daisuke Matsubara

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Akiteru Goto

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Satoshi Ota

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Oguni Sachiko

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Shumpei Ishikawa

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Keiji Miyazawa

8

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Masashi Fukayama

9

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Toshiro Niki

10

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

publication date

22 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

14-22

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Update on epidermal growth factor receptor mutations in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

c-Met: structure, functions and potential for therapeutic inhibition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Hepatocyte growth factor, its receptor, and their potential value in cancer therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Differential expression of Met/hepatocyte growth factor receptor in subtypes of non-small cell lung cancers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

The tumour-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Activation of c-Met (hepatocyte growth factor receptor) in human gastric cancer tissue

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

c-Met activation in lung adenocarcinoma tissues: an immunohistochemical analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Human lung cancer cell line producing hepatocyte growth factor/scatter factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Allelic dosage analysis with genotyping microarrays.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Hypoxia increases the motility of lung adenocarcinoma cell line A549 via activation of the epidermal growth factor receptor pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

The presence of scatter factor in patients with metastatic spread to the pleura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Cell adhesion system and human cancer morphogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Integrin signalling during tumour progression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00640.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2007.00640.X

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40063867&oldid=2228945937"